Cargando…

Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report

RATIONALE: Hypereosinophilic syndrome (HES) is a rare disorder characterized by hypereosinophilia and organ damage. Some cases of HES are caused by the FIP1L1/PDGFRA fusion gene and respond to imatinib. FIP1L1/PDGFRA-positive HES occasionally evolves into chronic eosinophilic leukemia or into anothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamamoto, Masayo, Ikuta, Katsuya, Toki, Yasumichi, Hatayama, Mayumi, Shindo, Motohiro, Torimoto, Yoshihiro, Okumura, Toshikatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392760/ https://www.ncbi.nlm.nih.gov/pubmed/28885361 http://dx.doi.org/10.1097/MD.0000000000008001

Ejemplares similares

Pseudogout Attack after Pegfilgrastim Administration in Anaplastic Large Cell Lymphoma
por: Hatayama, Mayumi, et al.
Publicado: (2018)

FIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus
por: Locke, Margaret, et al.
Publicado: (2023)

Acquired hemophilia A associated with Epstein–Barr-virus-associated T/natural killer-cell lymphoproliferative disease: A case report
por: Yamamoto, Masayo, et al.
Publicado: (2021)

Ascites in a young male: idiopathic FIP1L1-PDGFRA-negative hypereosinophilic syndrome
por: Kasinathan, Ganesh, et al.
Publicado: (2020)

Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
por: Kim, Dae Sik, et al.
Publicado: (2018)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement
por: Kim, Tae Hee, et al.
Publicado: (2016)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
por: Shah, Shilpan, et al.
Publicado: (2014)

FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
por: Loules, Gedeon, et al.
Publicado: (2009)

Long-term outcomes of imatinib in patients with FIP1L1/PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China
por: Qu, Shi-Qiang, et al.
Publicado: (2016)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020)

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report
por: Ali, Salhah, et al.
Publicado: (2022)

Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL
por: Li, Bin, et al.
Publicado: (2016)

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing
por: Vanden Bempt, M, et al.
Publicado: (2016)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
por: Abu-Tineh, Mohammad, et al.
Publicado: (2021)

FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia: A Low-Burden Disease with Dramatic Response to Imatinib - A Report of 5 Cases from South India
por: Kumar, Anıl N., et al.
Publicado: (2014)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation
por: Balatzenko, Gueorgui, et al.
Publicado: (2011)

An Intriguing Case of Eosinophilia with FIP1L1/PDGFRA Rearrangement Who Presented as Thrombotic Thrombocytopenic Purpura
por: Alshehri, Hassan, et al.
Publicado: (2019)

Renal thrombotic microangiopathy and FIP1L1/PDGFRα-associated myeloproliferative variant of hypereosinophilic syndrome
por: Langlois, Anne Lyse, et al.
Publicado: (2013)

Hypereosinophilic Syndrome, Multiorgan Involvement and Response to Imatinib
por: Hana, Caroline K, et al.
Publicado: (2020)

Successful Control of Disseminated Intravascular Coagulation by Recombinant Thrombomodulin during Arsenic Trioxide Treatment in Relapsed Patient with Acute Promyelocytic Leukemia
por: Shindo, Motohiro, et al.
Publicado: (2012)

Identification of JAK2 as a Mediator of FIP1L1-PDGFRA-Induced Eosinophil Growth and Function in CEL
por: Li, Bin, et al.
Publicado: (2012)

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
por: Mandelker, Diana, et al.
Publicado: (2015)

Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine
por: Sato, Kazuya, et al.
Publicado: (2021)

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases
por: Legrand, Fanny, et al.
Publicado: (2013)

Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Fatal Outcome of Imatinib in a Patient with Idiopathic Hypereosinophilic Syndrome
por: Abugroun, Ashraf, et al.
Publicado: (2018)

Idiopathic hypereosinophilic syndrome presenting with severe vasculitis successfully treated with imatinib
por: Fraticelli, Paolo, et al.
Publicado: (2016)

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement
por: Farah, Sassi, et al.
Publicado: (2022)

Cardiac Manifestations from Non-FIP1L1-PDGFRα-Associated Hypereosinophilic Syndrome in a 13-Year-Old African American Boy
por: Salm, Cindy M., et al.
Publicado: (2009)

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
por: Joensuu, Heikki
Publicado: (2023)

Impact of the KIT/PDGFRA genotype on prognosis in imatinib‐naïve Japanese patients with gastrointestinal stromal tumor
por: Cho, Haruhiko, et al.
Publicado: (2021)

Leukemogenic kinase FIP1L1‐PDGFRA and a small ubiquitin‐like modifier E3 ligase, PIAS1, form a positive cross‐talk through their enzymatic activities
por: Ibata, Makoto, et al.
Publicado: (2017)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

The Rab11 effectors Fip5 and Fip1 regulate zebrafish intestinal development
por: Jewett, Cayla E., et al.
Publicado: (2020)

Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemia
por: Helbig, Grzegorz, et al.
Publicado: (2011)

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells
por: Shen, Yingying, et al.
Publicado: (2014)

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
por: Joensuu, Heikki, et al.
Publicado: (2023)

Body iron metabolism and pathophysiology of iron overload
por: Kohgo, Yutaka, et al.
Publicado: (2008)

Cytomegalovirus infection in patients with malignant lymphomas who have not received hematopoietic stem cell transplantation
por: Sato, Kazuya, et al.
Publicado: (2022)

Immunopathology of angioimmunoblastic lymphadenopathy.
por: Jones, D. B., et al.
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_lde0rjv7iqcaneef80k7sa5n41